Allergy/Asthma News

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.

Older parental age at delivery increased the risk for certain childhood allergic diseases in offspring, according to study results.

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo nodularis in the European Union, Galderma announced in a press release.

Infants with a diverse diet at age 9 months were less likely to develop food allergy by age 18 months, especially if they had a history of eczema, according to a study published by Pediatric Allergy and Immunology.

Patients with food allergies face many risks when they dine and travel away from home, but doctors need data to help prioritize and address these dangers.

With more and more younger clinicians trying to balance family time with their work, it can be difficult to get them involved in organizations and leadership positions.

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate to severe atopic dermatitis that topical therapies have not adequately controlled, according to a press release.

Self-guided cognitive behavioral therapy was non-inferior in reducing atopic dermatitis symptom severity as clinician-guided cognitive behavioral therapy, according to a study.

BOSTON — Patients who were taking lipid-lowering medications experienced more severe anaphylaxis after insect stings, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.